: GlaxoSmithKline defends itself against activist Elliott, recognizing need for ‘improved and sustained value’
Pharma giant responds to attack from U.S. activist fund Elliott, backing CEO Emma Walmsley.

from MarketWatch.com - Top Stories https://ift.tt/3ha5Uxi
via IFTTT
from MarketWatch.com - Top Stories https://ift.tt/3ha5Uxi
via IFTTT
Kommentare
Kommentar veröffentlichen